Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
Public ClinicalTrials.gov record NCT01393613. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the efficacy, safety, and tolerability of fixed doses of OPC-34712 versus placebo for the treatment of adult subjects with an acute relapse of schizophrenia.
Study identification
- NCT ID
- NCT01393613
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 674 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2011
- Primary completion
- Jan 31, 2014
- Completion
- Jan 31, 2014
- Last update posted
- Nov 25, 2015
2011 – 2014
United States locations
- U.S. sites
- 19
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72201 | — |
| Not listed | Springdale | Arkansas | 72764 | — |
| Not listed | Escondido | California | 92025 | — |
| Not listed | Long Beach | California | 90813 | — |
| Not listed | Orange | California | 92868 | — |
| Not listed | Pico Rivera | California | 90660 | — |
| Not listed | San Diego | California | 92102 | — |
| Not listed | North Miami | Florida | 33161 | — |
| Not listed | North Miami | Florida | 33162 | — |
| Not listed | Overland Park | Kansas | 66212 | — |
| Not listed | Lake Charles | Louisiana | 70629 | — |
| Not listed | Shreveport | Louisiana | 71104 | — |
| Not listed | Flowood | Mississippi | 39232 | — |
| Not listed | St Louis | Missouri | 63118 | — |
| Not listed | Buffalo | New York | 14215 | — |
| Not listed | Memphis | Tennessee | 38119 | — |
| Not listed | Austin | Texas | 78756 | — |
| Not listed | Dallas | Texas | 75243 | — |
| Not listed | Houston | Texas | 77007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01393613, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 25, 2015 · Synced Sep 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01393613 live on ClinicalTrials.gov.